ARK Genomic Revolution ETF

The fund is an actively-managed exchange-traded fund (ETF) that will invest under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including healthcare, information technology, materials, energy and consumer discretionary, that are relevant to the fund's investment theme of the genomics revolution (Genomics Revolution Companies). It is non-diversified.

The current price of ARKG ETF is 22.97 USD — it has decreased by 0.00% in the past 24 hours. Watch ARKG ETF price performance more closely on the advanced chart.

ARKG ETF has decreased by -4.23% in the past week, has decreased by -14.26% in the past month, and has decreased by -22.03% in the past year. See more data on ARKG ETF chart.

As of 13 Mar 2025, the largest holdings include Crispr Therapeutics AG, Twist Bioscience Corp, Recursion Pharmaceuticals Inc, Tempus AI, Inc. Class A Common Stock, Natera Inc, Adaptive Biotechnologies Corp. See the full list of ARKG ETF holdings.

The ARKG ETF consists of 33 holdings, including Crispr Therapeutics AG, Twist Bioscience Corp, Recursion Pharmaceuticals Inc and others. See the full list of ARKG ETF holdings.

As of 13 Mar 2025, the ARKG ETF consists of 33 holdings. See the full list of ARKG ETF holdings.

The ARKG ETF sectors include Healthcare, Basic Materials, Consumer Cyclical, Financial Services, Real Estate and more.

The easiest way to buy ARKG ETF is through an online broker. Some of the popular names are Vanguard, Fidelity, Schwab. Simply open an account, follow the procedures, and start trading. Alternatively, you can practice trading ETFs on Profit.com in Playtrade Tournaments or choose a recommended broker to trade directly.